Browse drugs

…2.67, 71 subjects were on oral hypoglycemic medications such as metformin, sulfonylureas, pioglitazone, DPP-4 inhibitors, and SGLT2 inhib…

… in the world to approve a generic form of the blockbuster drug Ozempic (semaglutide), made possible after its manufacturer, Novo Nordi…

…ks.2 However, no real-world data exist investigating the use of tirzepatide in patients with type 2 diabetes mellitus (T2DM) and MASLD to u…

…GPs will be able to prescribe semaglutide (Wegovy) to overweight patients who have had a heart attack or …

…ient, with ICERs generally below willingness-to-pay thresholds. Dapagliflozin was cost saving in type 2 diabetes (T2D) in the United Kingdom …

…CI −0.53 to 0.86 events per 1000 person-years) or compared with DPP-4is (HR 0.94; 95% CI 0.71 to 1.24, rate difference −0.18; 95% CI −0…

…Orforglipron, a new glucagon-like peptide-1 (GLP-1) receptor agonist pill, l…

…ucagon-like peptide-1 (GLP-1) receptor agonist weight loss drug Wegovy (semaglutide), saying that its first direct to consumer TV adve…

…A new safety warning on semaglutide has been issued by the UK drugs regulator.…

… now in use—semaglutide (Wegovy), produced by Novo Nordisk, and tirzepatide (Mounjaro), produced by Eli Lilly—have been shown in clinical t…

…d-stage liver diseases. However, only two drugs, resmetirom and semaglutide, have been approved by the US food and drug administration (FDA…

… a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it…